Results 71 to 80 of about 30,760,747 (299)

Issues in regulatory guidelines for data monitoring committees.

, 2004
As clinical trials have emerged as the major research method for evaluating new interventions, the process for monitoring intervention safety and benefit has also evolved.
Kaplan, Richard, Seto, Belinda, DeMets, David, Ellenberg, Susan, Levine, Robert, Stump, David, Fleming, Thomas, Pocock, Stuart, Held, Peter, Rockhold, Frank, Neaton, James, Snapinn, Steve, Dixon, Dennis, Julian, Desmond, Temple, Robert, Siegel, Jay, Packer, Milton, Whitley, Richard, Califf, Robert   +18 more
core   +1 more source

Analysis of factors for non-disclosure of information by doctor-investigators in clinical trials in Malaysia [PDF]

, 2017
In clinical trials, the need to obtain patient’s consent by way of informed consent has been mandatorily imposed as a way to protect the patient as subject.Unfortunately, many studies have shown that the doctor-investigators had failed to disclose full ...
Abdullah, Nor Anita, Megat Latif, Hairuddin, Yusof, Yuhanif, Che Ngah, Anisah, Md Desa, Md Rejab   +4 more
core   +1 more source

Data Monitoring Committees and clinical trials: From scientific justification to organisation

Therapies
Clinical trials often last several months or even several years. As the trial progresses, it can be tempting to find out whether the data obtained already answers the question posed at the start of the trial in order to stop inclusions or monitoring earlier. However, knowing and taking into account interim results can sometimes compromise the integrity
Locher, Clara, Laporte, Silvy, Derambure, Peggy, Chassany, Olivier, Girault, Cécile, Avakiantz, Alix, Bahans, Claire, Deplanque, Dominique, Fustier, Pierre, Germe, Anne Françoise, Kassai Koupai, Behrouz, Lacoste, Louis, Petitpain, Nadine, Roustit, Matthieu, Simon, Tabassome, Train, Cecile, Cucherat, Michel   +16 more
openaire   +4 more sources

Partial FAK suppression promotes tumor growth, an effect reversed by macrophage p110δ PI3K inactivation

Molecular Oncology, EarlyView.
Partial inhibition of focal adhesion kinase (FAK) can paradoxically promote tumor growth, rather than simply producing a weaker antitumor effect than that observed with strong FAK suppression. In breast cancer and melanoma models, targeting p110δ PI3K, particularly in macrophages, counteracted these tumor‐promoting effects, highlighting the importance ...
Lydia Xenou, Niki Tzenaki, Anna Tsapara, Maria Tzardi, Evangelia A. Papakonstanti   +4 more
wiley   +1 more source

Should data monitoring committees assess efficacy when considering safety in trails in acute stroke? [PDF]

, 2007
The primary role of a trials Data Monitoring Committee (DMC) is to ensure the safety of enrolled patients. In stroke trials, safety is monitored typically by comparing death and stroke specific events between treatment groups.
Wahlgren, Nils-Gunnar, Bath, Philip M.W., Gray, Laura J.   +2 more
core  

CONSIDERACIONES ÉTICAS EN EL PROCESO DE UNA PUBLICACIÓN CIENTÍFICA

Revista Médica Clínica Las Condes, 2019
Resumen: La publicación de las investigaciones científicas ha tenido gran importancia en la sociedad, ya que el principal objetivo hasta hace poco había sido la divulgación de los conocimientos, con el fin de mejorar el desarrollo de la humanidad.
Dulce María Espinoza
doaj   +1 more source

Profiling neoadjuvant therapy response in rectal cancer using meta‐analysis of publicly available transcriptomic RNA‐seq datasets

Molecular Oncology, EarlyView.
This study integrates publicly available transcriptomic datasets to identify molecular signatures associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. By analyzing a combination of multiple cohorts with bioinformatics approaches, we reveal biological pathways and immune‐related features that may improve ...
Aleksandra Stanojevic, Rafael Stroggilos, Mladen Marinkovic, Ana Djuric, Suzana Stojanovic‐Rundic, Radmila Jankovic, Sergi Castellvi‐Bel, Remond J.A. Fijneman, Antonia Vlahou, Jerome Zoidakis, Milena Cavic   +10 more
wiley   +1 more source

Assessment of outcome in clinical trials in mild Alzheimer 19s disease: urgent time for a rethink? [PDF]

, 2013
Introduction: A major barrier for clinical trials in Alzheimer's disease is the lack of sensitive clinical endpoints for the early stages. Until recently, regulatory agencies have required demonstration of improvement in two disease domains, cognition ...
McGoldrick, S., Duffy, Fiona, McGoldrick, Susan, Reynish, Emma, Kelly, Fiona, Morrison, Y., Wilson, L., Bennett, Crispin, Wilson, J T Lindsay, Bennett, C., Morrison, Yvonne, Duffy, F., Reynish, E.   +12 more
core  

All-arthroscopic versus mini-open repair of small or moderate-sized rotator cuff tears: A protocol for a randomized trial [NCT00128076]

BMC Musculoskeletal Disorders, 2006
Background Rotator cuff tears are the most common source of shoulder pain and disability. Only poor quality studies have compared mini-open to arthroscopic repair, leaving surgeons with inadequate evidence to support optimal, minimally-invasive repair ...
Razmjou Helen, Holtby Richard, MacDermid Joy C, Bryant Dianne   +3 more
doaj   +1 more source

Extracellular vesicle lipidomics liquid biopsy reveals systemic and tumor microenvironment metabolic reprogramming in ovarian cancer

Molecular Oncology, EarlyView.
Extracellular vesicle (EV) lipidomic profiling of plasma and ascites from patients with high‐grade serous ovarian cancer and of ovarian cancer cell lines reveals enrichment of triglycerides (TGs), diacylglycerols (DGs), phosphatidylcholine (PCs), sphingomyelins (SMs), reflecting tumor metabolic reprogramming.
Shikha Rani, Dominic Guanzon, Andrew Lai, Katherin Scholz‐Romero, Sarah Reed, Edita Ritmejeryte, Rohan Lourie, Naven Chetty, Kaltin Ferguson, Carlos Salomon   +9 more
wiley   +1 more source